Lilly to boost diabetes drug production with $450M factory investment

Eli Lilly and Co. plans to build a new $2.5 billion high-tech manufacturing site in Alzey, Rhineland-Palatinate, Germany to expand its global parenteral product and device manufacturing network and support increased demand for its diabetes and obesity portfolio. With the planned manufacturing facility in Alzey, Lilly will operate a total of six manufacturing sites in […]

Chiesi, Haisco Partner on DPP1 Inhibitor for Respiratory Diseases

Chiesi Farmaceutici S.p.A, an international, research-focused biopharmaceuticals and healthcare group, and Haisco Pharmaceutical Group Co. Ltd entered a licensing agreement to develop, manufacture, and commercialize outside China and adjacent territories (Hong Kong SAR, Macau SAR, and Taiwan District) HSK31858, a novel, reversible dipeptidyl peptidase 1 (DPP1) inhibitor for respiratory diseases. With this agreement, Chiesi will […]

Cryoport’s CRYOPDP Expands U.S. Footprint with Acquisition of Bluebird Express

Cryoport, Inc., a leading global provider of innovative products and services to the fast-growing cell and gene therapy industry enabling the future of medicine for a new era of life sciences announced the expansion of its global supply chain network with the acquisition of Bluebird Express, LLC, a provider of time-sensitive domestic and international transportation […]

The Role of Robotics in Urological Surgeries: Precision, Outcomes, and Training

The advancements in technology and the desire for minimally invasive surgeries have converged to propel the field of robotic urological surgeries to the forefront. As the healthcare landscape evolves, robotics’ importance is becoming increasingly evident, particularly within the urological sphere. This article explores how robotic technology has elevated surgical precision, improved patient outcomes, and transformed […]

Connected Devices Making Their Presence Felt In Pharma

The market when it comes to connected drug delivery devices is going through rapid growth, with an expected annual market growth rate of more than 20% between 2023 and 2030. This progress is driven, in part, by the increasing trend of self-administration of medications outside of the traditional healthcare landscape. However, it is likely that […]

Reference Approval Agencies Expanded By NPRA In Malaysia

The National Pharmaceutical Regulatory Agency- NPRA of Malaysia has recently gone on to revise its guidelines with regards to the approval pathways for medicines that have already been authorized in certain overseas territories. The changes made by NPRA go on to include adding new reference regulatory agencies as well as shortening approval timelines. It is well […]

Symbiosis Pharmaceutical Services granted MHRA licence following a £1M Investment

Specialist Contract Development and Manufacturing Organisation (CDMO), Symbiosis Pharmaceutical Services, has launched new in-house analytical and microbiological capabilities to enable testing of small molecule, biological, and Advanced Therapeutic Medicinal Products (ATMP) biopharmaceuticals following a £1m plus investment. Fully approved by the UK Regulatory Agency the MHRA, this expansion of their service offering will strategically enhance […]

Advanced Biotech Cooperation To Boost Korea-UK Tech Ties

During South Korean President Yoon Suk Yeol’s state visit to the UK, several MoUs were signed between major universities as well as research institutes from South Korea and the UK. These MoUs emphasized fostering advanced biotechnology partnerships in areas ranging from synthetic biology and the development of AI-based drugs to brain research. It is well […]

Taiwan, US Team Up To Establish A Digital Health Ecosystem

The Healthcare Information and Management Systems Society- HIMSS – US as well as the National Health Insurance Administration- NHIA in Taiwan, which happens to be an agency under the Ministry of Health and Welfare, have gone on to enter into an agreement so as to collaborate and work together to promote digital change in numerous […]

DoKaSch Temperature Solutions expands global presence with new depot in United Arab Emirates

DoKaSch Temperature Solutions, a leading provider of temperature-controlled logistics solutions, is pleased to announce the opening of its new depot in United Arab Emirates. This strategic move strengthens the company’s presence in the Middle East and enhances its global network. The new depot is in Dubai close to Dubai-World Central Airport, strategically placed due to […]